- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Board approved Q2/H1 financial results (Revenue Rs 586.11 Cr, PAT Rs 36.88 Cr). Company granted 35,000 employee stock options and allotted 14,400 shares. Additionally, approved up to $8 million investment in its Saudi Arabia chemical subsidiary for expansion.